SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Pastimes : Discussion Thread -- Ignore unavailable to you. Want to Upgrade?

To: TimF who wrote (1506)8/10/2008 11:47:21 AM
From: c.hinton  Read Replies (1) | Respond to of 3816
 
hmmmm! no room for price cutting?
In 1990, a staggering 36 percent of sales revenue went into [marketing and administration], and that proportion remained about the same for more than a decade.
The former chairman and CEO of Bristol-Myers Squibb, Charles A. Heimbold, Jr., made $74,890,918 in 2001, not counting his $76,095,611 worth of unexercised stock options. The chairman of Wyeth made $40,521,011, exclusive of his $40,629,459 in stock options.

mbtmag.com



To: TimF who wrote (1506)8/10/2008 11:49:35 AM
From: c.hinton  Respond to of 3816
 
i really like the warnings on tv drug adds here in america.......ie if you have an erection for more than 4 hours see your doctor(viagra)....or side effects may include bleeding or life threatening reactions,increaced libido and a desire to gamble for an whole line of drugs marketed directly to an unimformed public.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News